316 related articles for article (PubMed ID: 16781734)
21. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
[TBL] [Abstract][Full Text] [Related]
23. Modification of the substrate specificity of porcine pepsin for the enzymatic production of bovine hide gelatin.
Galea CA; Dalrymple BP; Kuypers R; Blakeley R
Protein Sci; 2000 Oct; 9(10):1947-59. PubMed ID: 11106168
[TBL] [Abstract][Full Text] [Related]
24. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
[TBL] [Abstract][Full Text] [Related]
25. Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin.
Ragusa S; Mouchet P; Lazennec C; Dive V; Meinnel T
J Mol Biol; 1999 Jun; 289(5):1445-57. PubMed ID: 10373378
[TBL] [Abstract][Full Text] [Related]
26. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
Pereira NA; Song Z
Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
[TBL] [Abstract][Full Text] [Related]
27. CaSPredictor: a new computer-based tool for caspase substrate prediction.
Garay-Malpartida HM; Occhiucci JM; Alves J; Belizário JE
Bioinformatics; 2005 Jun; 21 Suppl 1():i169-76. PubMed ID: 15961454
[TBL] [Abstract][Full Text] [Related]
28. Effect of caspase cleavage-site phosphorylation on proteolysis.
Tözsér J; Bagossi P; Zahuczky G; Specht SI; Majerova E; Copeland TD
Biochem J; 2003 May; 372(Pt 1):137-43. PubMed ID: 12589706
[TBL] [Abstract][Full Text] [Related]
29. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
[TBL] [Abstract][Full Text] [Related]
30. ADAM33 enzyme properties and substrate specificity.
Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
[TBL] [Abstract][Full Text] [Related]
31. Phage display and crystallographic analysis reveals potential substrate/binding site interactions in the protein secretion chaperone CsaA from Agrobacterium tumefaciens.
Feldman AR; Shapova YA; Wu SS; Oliver DC; Heller M; McIntosh LP; Scott JK; Paetzel M
J Mol Biol; 2008 Jun; 379(3):457-70. PubMed ID: 18462752
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
McGrath ME; Mirzadegan T; Schmidt BF
Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
[TBL] [Abstract][Full Text] [Related]
33. Coulombic effects of remote subsites on the active site of ribonuclease A.
Fisher BM; Schultz LW; Raines RT
Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
[TBL] [Abstract][Full Text] [Related]
34. Extended cleavage specificity of mMCP-1, the major mucosal mast cell protease in mouse-high specificity indicates high substrate selectivity.
Andersson MK; Pemberton AD; Miller HR; Hellman L
Mol Immunol; 2008 May; 45(9):2548-58. PubMed ID: 18313755
[TBL] [Abstract][Full Text] [Related]
35. Cleavage efficiency of the novel aspartic protease yapsin 1 (Yap3p) enhanced for substrates with arginine residues flanking the P1 site: correlation with electronegative active-site pockets predicted by molecular modeling.
Olsen V; Guruprasad K; Cawley NX; Chen HC; Blundell TL; Loh YP
Biochemistry; 1998 Mar; 37(9):2768-77. PubMed ID: 9485427
[TBL] [Abstract][Full Text] [Related]
36. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
Bailey D; Cooper JB
Protein Sci; 1994 Nov; 3(11):2129-43. PubMed ID: 7703859
[TBL] [Abstract][Full Text] [Related]
37. Mapping of the substrate binding site of human leukocyte chymotrypsin (cathepsin G) using tripeptidyl-p-nitroanilide substrates.
Szabó G; Tözsér J; Aurell L; Elödi P
Acta Biochim Biophys Hung; 1986; 21(4):349-62. PubMed ID: 3109179
[TBL] [Abstract][Full Text] [Related]
38. The inhibitor profiling of the caspase family of proteases using substrate-derived peptide glyoxals.
Murphy DJ; Walker B; Ryan CA; Martin SL
Biochem Biophys Res Commun; 2010 Nov; 402(3):483-8. PubMed ID: 20955686
[TBL] [Abstract][Full Text] [Related]
39. Structural and enzymatic insights into caspase-2 protein substrate recognition and catalysis.
Tang Y; Wells JA; Arkin MR
J Biol Chem; 2011 Sep; 286(39):34147-54. PubMed ID: 21828056
[TBL] [Abstract][Full Text] [Related]
40. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
Lin J; Cassidy CS; Frey PA
Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
